Valuation: Tiansheng Pharmaceutical Group Co., Ltd.

Market Cap 196.84Cr 29Cr 26Cr 24Cr 22Cr 42Cr 2.83TCr 42Cr 292.92Cr 113.93Cr 1.44TCr 110.2Cr 107.84Cr 4.64TCr P/E 2024
-16.5x
P/E 2025 -27.9x
Enterprise Value 204.73Cr 31Cr 27Cr 25Cr 23Cr 43Cr 2.94TCr 44Cr 304.67Cr 118.5Cr 1.5TCr 114.62Cr 112.16Cr 4.83TCr EV / Sales 2024
2.7x
EV / Sales 2025 3.16x
Free-Float
52.28%
Yield 2024 *
-
Yield 2025 -
1 day+1.14%
1 week+1.14%
1 month+6.54%
3 months+21.85%
6 months+25.56%
Current year+27.37%
1 month 5.72
Extreme 5.72
6.28
Current year 4.32
Extreme 4.32
6.28
1 year 4.32
Extreme 4.32
6.28
3 years 3.17
Extreme 3.17
6.28
5 years 3.17
Extreme 3.17
6.28
10 years 3.17
Extreme 3.17
35.18
Manager TitleAgeSince
Chief Executive Officer 33 06/12/2018
Director of Finance/CFO 52 23/12/2013
Corporate Officer/Principal 54 11/12/2020
Director TitleAgeSince
Chairman 33 06/12/2018
Director/Board Member 54 11/12/2020
Director/Board Member 66 11/12/2020
Date Insider Type Main position Quantity % Market Cap. Importance
25/07/23 Sell

Chief Financial Officer

43,100 0.0205%
Change 5-day change 1-year change 3-year change Capi.($)
+1.14%+1.14%+25.05%+23.55% 29Cr
+1.26%-2.29%+36.97%+104.79% 1,03200Cr
+0.73%-4.78%+35.41%+61.62% 61TCr
+0.35%+1.29%+15.86%+79.90% 47TCr
+1.72%-4.92%+59.84%+36.64% 35TCr
+0.40%+0.14%+21.29%+40.99% 34TCr
+0.56%-3.09%+10.76%+32.59% 27TCr
-0.25%-3.78%-6.03%+9.29% 25TCr
-0.09%-4.97%+36.88%+50.52% 22TCr
-0.28%-4.66%+26.99%+92.98% 18TCr
Average +0.26%-2.66%+26.30%+53.29% 37.15TCr
Weighted average by Cap. -0.07%-3.18%+29.54%+66.99%

Financials

2024 2025
Net sales 57Cr 8.5Cr 7.54Cr 7.06Cr 6.4Cr 12Cr 819.12Cr 12Cr 85Cr 33Cr 417.87Cr 32Cr 31Cr 1.34TCr 51Cr 7.67Cr 6.81Cr 6.37Cr 5.77Cr 11Cr 739.14Cr 11Cr 77Cr 30Cr 377.07Cr 29Cr 28Cr 1.21TCr
Net income -8.74Cr -1.3Cr -1.16Cr -1.08Cr -98.16L -1.85Cr -125.67Cr -1.87Cr -13Cr -5.06Cr -64Cr -4.89Cr -4.79Cr -206.09Cr -5.54Cr -82.66L -73.38L -68.67L -62.24L -1.18Cr -80Cr -1.18Cr -8.25Cr -3.21Cr -41Cr -3.1Cr -3.04Cr -130.68Cr
Net Debt 9.72Cr 1.45Cr 1.29Cr 1.2Cr 1.09Cr 2.06Cr 139.74Cr 2.08Cr 14Cr 5.63Cr 71Cr 5.44Cr 5.32Cr 229.16Cr 7.89Cr 1.18Cr 1.05Cr 97.79L 88.64L 1.67Cr 113.48Cr 1.69Cr 12Cr 4.57Cr 58Cr 4.42Cr 4.32Cr 186.11Cr
Projected Income Statement - Annual - Tiansheng Pharmaceutical Group Co., Ltd.
Logo Tiansheng Pharmaceutical Group Co., Ltd.
Tiansheng Pharmaceutical Group Co Ltd is a China-based company primarily engaged in drug R&D, production, sales, and the cultivation and processing of traditional Chinese medicinal materials. The Company's products include tablets, capsules, granules, teas, pills, and injections. Product varieties cover pediatrics, gynecology, cardiovascular system, digestive system, orthopedics, respiratory medicine, and anti-infective treatment areas. The Company's products are mainly sold to the domestic market.
Employees
1,273
Date Price Change Volume
30/26/30 CN¥6.190 +1.14% 42,83,300
29/26/29 CN¥6.120 +1.32% 54,82,300
  1. Stock Market
  2. Stocks
  3. 002872 Stock